Why Your Hearing Aid Might Be Protecting Your Brain

The connection between hearing and brain health is one of the most underappreciated findings in dementia research. A systematic review and meta-analysis by Yeo and colleagues, published in JAMA Neurology in 2023, examined 31 studies involving 137,484 participants and found that hearing aid use was associated with a 19% reduction in the hazard of long-term cognitive decline. The authors were from the Yong Loo Lin School of Medicine at the National University of Singapore, making this finding particularly relevant to our regional context.

The mechanism is not fully understood, but hearing loss is thought to place chronic cognitive load on the brain. When the auditory system struggles to process sound, other cognitive resources are recruited to compensate. Over years and decades, this silent strain may accelerate the kind of cognitive decline associated with vascular cognitive impairment and Alzheimer's disease.

At Gray Matter Solutions, insights from studies like Yeo et al. inform how we think about the full picture of brain health risk. ReCOGnAIze was designed to capture the earliest signals of cognitive change in vascular risk populations. Hearing is one piece of that larger picture, and the research strongly supports addressing it early.

On the biomarker front, a meta-analysis by Malek-Ahmadi and colleagues from Banner Alzheimer's Institute, published in JAMA Neurology in 2026, analysed data from 7,834 participants across 18 studies and found that plasma p-tau217 can reliably identify amyloid-positive individuals without cognitive impairment, with an area under the curve of 0.87. The message is consistent: the biological processes underlying dementia begin years before diagnosis.

If you are over 50 and have not had a hearing assessment or a cognitive screening in the last two years, ask your doctor. A 15-minute assessment could give you a clearer picture of your brain health than you expect.